Fitchburg, WI, United States of America

John C Pirnstill

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by John C. Pirnstill

Introduction

John C. Pirnstill is a notable inventor based in Fitchburg, WI (US), recognized for his contributions to the field of medical technology. He holds three patents that focus on the preservation and application of skin substitutes, showcasing his commitment to advancing healthcare solutions.

Latest Patents

One of his latest patents is titled "Cryopreservation of viable human skin substitutes." This invention relates to systems and methods for preparing, storing, shipping, and using skin equivalents made by organotypic culture. It specifically addresses the cryopreservation of viable skin substitutes, ensuring their effectiveness for clinical use. Another significant patent is "Cold storage of organotypically cultured skin equivalents for clinical applications." This invention outlines systems and methods for storing, shipping, and using skin equivalents produced by organotypic culture at reduced temperatures, preferably between 2-8 degrees Celsius. The methods include sterile packaging of the grafts to maintain sterility and integrity until the time of use for grafting purposes.

Career Highlights

John C. Pirnstill is associated with Stratatech Corporation, where he applies his expertise in developing innovative solutions for skin substitutes. His work has significantly impacted the field of regenerative medicine, particularly in improving the viability and usability of skin grafts.

Collaborations

He has collaborated with notable colleagues, including B Lynn Allen-Hoffmann and Kenneth R Gratz, contributing to advancements in their shared field of research.

Conclusion

John C. Pirnstill's innovative work in the preservation of skin substitutes highlights his dedication to improving medical technologies. His patents reflect a significant contribution to the field, enhancing the potential for clinical applications in regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…